EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identifying Cardiac Adverse Event Signals for Natural Products Using Disproportionality Analysis of the FDA Adverse Event Reporting System (FAERS)

Christina L. Kazarov, Richard D. Boyce, Sanya B. Taneja, Kojo Abanyie, Maryann R. Sestito, Sandra L. Kane-Gill

Journal of Clinical Pharmacy and Therapeutics · 2026-01 · 2026 (1)

DOI: 10.1155/jcpt/8979418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 02.08.2026. Verfasst von Christina L. Kazarov und 5 weiteren Autor:innen. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center for Complementary and Integrative Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Marketing regulations for natural products (NPs), such as herbal supplements, are less stringent than for prescription or over‐the‐counter medications. This paucity of regulations and widespread use demonstrates the need to better understand potential safety risks of NPs. The aim of this disproportionality analysis was to use the FDA Adverse Event Reporting System (FAERS) database to identify cardiac adverse event (AE) signals associated with NPs.

Methods

FAERS reports (2004 Q1–2021 Q3) were searched for cardiac AEs and NP use. Reporting odds ratios (ROR) were calculated for each cardiac AE–NP pair. Pairs with ≥ 3 reports and a 95% confidence interval for the ROR ≥ 2.0 underwent further analysis using the observed‐to‐expected (OE) ratio with shrinkage. Signals with an OE ratio 95% credibility interval > 1.0 were considered significant safety signals. Detailed assessments of each report were conducted for content validity based on clinical interpretation.

Results

A total of 2484 spontaneous reports listing cardiac AEs and NPs were identified, resulting in 705 preliminary NP–AE pairs for 74 unique NPs. Subsequent OE ratio calculations identified 10 significant safety signals for 8 unique NPs.

Conclusion

Several AE signals for NPs had a disproportionate number of reports when compared to all other product reports within FAERS. After a literature search for supporting evidence, we found that four NPs are likely associated with cardiac AEs (guarana, hemp extract, licorice, and ginkgo) and four require further investigation (seawrack, soybean, celery, and Panax ginseng ). Despite limitations inherent to spontaneous reporting systems, this study highlights potential cardiac safety risks associated with NP use.

Förderung

  • National Center for Complementary and Integrative Health

Zitieren

APA

Kazarov, C. L., Boyce, R. D., Taneja, S. B., Abanyie, K., Sestito, M. R., & Kane-Gill, S. L. (2026). Identifying Cardiac Adverse Event Signals for Natural Products Using Disproportionality Analysis of the FDA Adverse Event Reporting System (FAERS). Journal of Clinical Pharmacy and Therapeutics, 2026(1). https://doi.org/10.1155/jcpt/8979418

Vancouver

Kazarov CL, Boyce RD, Taneja SB, Abanyie K, Sestito MR, Kane-Gill SL. Identifying Cardiac Adverse Event Signals for Natural Products Using Disproportionality Analysis of the FDA Adverse Event Reporting System (FAERS). Journal of Clinical Pharmacy and Therapeutics. 2026;2026(1). doi:10.1155/jcpt/8979418

BibTeX
@article{Kazarov2026,
  author = {Kazarov, Christina L. and Boyce, Richard D. and Taneja, Sanya B. and Abanyie, Kojo and Sestito, Maryann R. and Kane-Gill, Sandra L.},
  title = {Identifying Cardiac Adverse Event Signals for Natural Products Using Disproportionality Analysis of the FDA Adverse Event Reporting System (FAERS)},
  journal = {Journal of Clinical Pharmacy and Therapeutics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jcpt/8979418}
}
Kostenlos starten →